English
简体中文
Total: £ 56.28
Published Date: 2026-01-23 | Pages: 120 | Tables: 119 | Medical Care
The global Psychobiotics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Psychobiotics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Psychobiotics are a novel class of probiotics that influence brain function and behavior through the gut-brain axis. The gut-brain axis refers to the bidirectional communication between the central nervous system and the gut microbiome, linking cognitive and emotional centers of the brain with intestinal functions. This axis plays a crucial role in influencing mood, cognition, and overall mental health.
The North American market for Psychobiotics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Psychobiotics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Psychobiotics include Lallemand Inc, Novonesis (Novozymes A/S), Bened Biomedical, Sabinsa Corporation, DuPont Nutrition & Biosciences, Kerry Group, Bioprox, Chr. Hansen, Mystical Biotech, Synbiotech, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Psychobiotics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Psychobiotics. The Psychobiotics market size, estimates, and forecasts are provided in terms of sales volume (Ton) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Psychobiotics market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Psychobiotics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Lallemand Inc
Novonesis (Novozymes A/S)
Bened Biomedical
Sabinsa Corporation
DuPont Nutrition & Biosciences
Kerry Group
Bioprox
Chr. Hansen
Mystical Biotech
Synbiotech
Glac biotech Co., Ltd.
Ildong Bioscience Co. Ltd
JuneYao Health (BioGrowing Co., Ltd)
Unique Biotech
Segment by Type
Bifidobacterium Longum
Lactobacillus Acidophilus
Lactobacillus Casei
Other
by Application
Depression
Stress
Anxiety
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Psychobiotics manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Psychobiotics sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Psychobiotics Market Overview
1.1 Product Definition
1.2 Psychobiotics by Type
1.2.1 Global Psychobiotics Market Value by Type: 2025 vs 2032
1.2.2 Bifidobacterium Longum
1.2.3 Lactobacillus Acidophilus
1.2.4 Lactobacillus Casei
1.2.5 Other
1.3 Psychobiotics by Application
1.3.1 Global Psychobiotics Market Value by Application: 2025 vs 2032
1.3.2 Depression
1.3.3 Stress
1.3.4 Anxiety
1.3.5 Other
1.4 Global Psychobiotics Market Size Estimates and Forecasts
1.4.1 Global Psychobiotics Revenue 2021–2032
1.4.2 Global Psychobiotics Sales 2021–2032
1.4.3 Global Psychobiotics Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Psychobiotics Market Competition by Manufacturers
2.1 Global Psychobiotics Sales Market Share by Manufacturers (2021–2026)
2.2 Global Psychobiotics Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Psychobiotics Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Psychobiotics, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Psychobiotics, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Psychobiotics, Product Types and Applications
2.7 Global Key Manufacturers of Psychobiotics, Date of Entry into the Industry
2.8 Global Psychobiotics Market Competitive Situation and Trends
2.8.1 Global Psychobiotics Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Psychobiotics Players Market Share by Revenue
2.8.3 Global Psychobiotics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Psychobiotics Market Scenario by Region
3.1 Global Psychobiotics Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Psychobiotics Sales by Region: 2021–2032
3.2.1 Global Psychobiotics Sales by Region: 2021–2026
3.2.2 Global Psychobiotics Sales by Region: 2027–2032
3.3 Global Psychobiotics Revenue by Region: 2021–2032
3.3.1 Global Psychobiotics Revenue by Region: 2021–2026
3.3.2 Global Psychobiotics Revenue by Region: 2027–2032
3.4 North America Psychobiotics Market Facts & Figures by Country
3.4.1 North America Psychobiotics Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Psychobiotics Sales by Country (2021–2032)
3.4.3 North America Psychobiotics Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Psychobiotics Market Facts & Figures by Country
3.5.1 Europe Psychobiotics Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Psychobiotics Sales by Country (2021–2032)
3.5.3 Europe Psychobiotics Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Psychobiotics Market Facts & Figures by Region
3.6.1 Asia Pacific Psychobiotics Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Psychobiotics Sales by Region (2021–2032)
3.6.3 Asia Pacific Psychobiotics Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Psychobiotics Market Facts & Figures by Country
3.7.1 Latin America Psychobiotics Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Psychobiotics Sales by Country (2021–2032)
3.7.3 Latin America Psychobiotics Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Psychobiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Psychobiotics Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Psychobiotics Sales by Country (2021–2032)
3.8.3 Middle East and Africa Psychobiotics Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Psychobiotics Sales by Type (2021–2032)
4.1.1 Global Psychobiotics Sales by Type (2021–2026)
4.1.2 Global Psychobiotics Sales by Type (2027–2032)
4.1.3 Global Psychobiotics Sales Market Share by Type (2021–2032)
4.2 Global Psychobiotics Revenue by Type (2021–2032)
4.2.1 Global Psychobiotics Revenue by Type (2021–2026)
4.2.2 Global Psychobiotics Revenue by Type (2027–2032)
4.2.3 Global Psychobiotics Revenue Market Share by Type (2021–2032)
4.3 Global Psychobiotics Price by Type (2021–2032)
5 Segment by Application
5.1 Global Psychobiotics Sales by Application (2021–2032)
5.1.1 Global Psychobiotics Sales by Application (2021–2026)
5.1.2 Global Psychobiotics Sales by Application (2027–2032)
5.1.3 Global Psychobiotics Sales Market Share by Application (2021–2032)
5.2 Global Psychobiotics Revenue by Application (2021–2032)
5.2.1 Global Psychobiotics Revenue by Application (2021–2026)
5.2.2 Global Psychobiotics Revenue by Application (2027–2032)
5.2.3 Global Psychobiotics Revenue Market Share by Application (2021–2032)
5.3 Global Psychobiotics Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Lallemand Inc
6.1.1 Lallemand Inc Company Information
6.1.2 Lallemand Inc Description and Business Overview
6.1.3 Lallemand Inc Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Lallemand Inc Psychobiotics Product Portfolio
6.1.5 Lallemand Inc Recent Developments/Updates
6.2 Novonesis (Novozymes A/S)
6.2.1 Novonesis (Novozymes A/S) Company Information
6.2.2 Novonesis (Novozymes A/S) Description and Business Overview
6.2.3 Novonesis (Novozymes A/S) Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Novonesis (Novozymes A/S) Psychobiotics Product Portfolio
6.2.5 Novonesis (Novozymes A/S) Recent Developments/Updates
6.3 Bened Biomedical
6.3.1 Bened Biomedical Company Information
6.3.2 Bened Biomedical Description and Business Overview
6.3.3 Bened Biomedical Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bened Biomedical Psychobiotics Product Portfolio
6.3.5 Bened Biomedical Recent Developments/Updates
6.4 Sabinsa Corporation
6.4.1 Sabinsa Corporation Company Information
6.4.2 Sabinsa Corporation Description and Business Overview
6.4.3 Sabinsa Corporation Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sabinsa Corporation Psychobiotics Product Portfolio
6.4.5 Sabinsa Corporation Recent Developments/Updates
6.5 DuPont Nutrition & Biosciences
6.5.1 DuPont Nutrition & Biosciences Company Information
6.5.2 DuPont Nutrition & Biosciences Description and Business Overview
6.5.3 DuPont Nutrition & Biosciences Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 DuPont Nutrition & Biosciences Psychobiotics Product Portfolio
6.5.5 DuPont Nutrition & Biosciences Recent Developments/Updates
6.6 Kerry Group
6.6.1 Kerry Group Company Information
6.6.2 Kerry Group Description and Business Overview
6.6.3 Kerry Group Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Kerry Group Psychobiotics Product Portfolio
6.6.5 Kerry Group Recent Developments/Updates
6.7 Bioprox
6.7.1 Bioprox Company Information
6.7.2 Bioprox Description and Business Overview
6.7.3 Bioprox Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bioprox Psychobiotics Product Portfolio
6.7.5 Bioprox Recent Developments/Updates
6.8 Chr. Hansen
6.8.1 Chr. Hansen Company Information
6.8.2 Chr. Hansen Description and Business Overview
6.8.3 Chr. Hansen Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Chr. Hansen Psychobiotics Product Portfolio
6.8.5 Chr. Hansen Recent Developments/Updates
6.9 Mystical Biotech
6.9.1 Mystical Biotech Company Information
6.9.2 Mystical Biotech Description and Business Overview
6.9.3 Mystical Biotech Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Mystical Biotech Psychobiotics Product Portfolio
6.9.5 Mystical Biotech Recent Developments/Updates
6.10 Synbiotech
6.10.1 Synbiotech Company Information
6.10.2 Synbiotech Description and Business Overview
6.10.3 Synbiotech Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Synbiotech Psychobiotics Product Portfolio
6.10.5 Synbiotech Recent Developments/Updates
6.11 Glac biotech Co., Ltd.
6.11.1 Glac biotech Co., Ltd. Company Information
6.11.2 Glac biotech Co., Ltd. Description and Business Overview
6.11.3 Glac biotech Co., Ltd. Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Glac biotech Co., Ltd. Psychobiotics Product Portfolio
6.11.5 Glac biotech Co., Ltd. Recent Developments/Updates
6.12 Ildong Bioscience Co. Ltd
6.12.1 Ildong Bioscience Co. Ltd Company Information
6.12.2 Ildong Bioscience Co. Ltd Description and Business Overview
6.12.3 Ildong Bioscience Co. Ltd Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Ildong Bioscience Co. Ltd Psychobiotics Product Portfolio
6.12.5 Ildong Bioscience Co. Ltd Recent Developments/Updates
6.13 JuneYao Health (BioGrowing Co., Ltd)
6.13.1 JuneYao Health (BioGrowing Co., Ltd) Company Information
6.13.2 JuneYao Health (BioGrowing Co., Ltd) Description and Business Overview
6.13.3 JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Product Portfolio
6.13.5 JuneYao Health (BioGrowing Co., Ltd) Recent Developments/Updates
6.14 Unique Biotech
6.14.1 Unique Biotech Company Information
6.14.2 Unique Biotech Description and Business Overview
6.14.3 Unique Biotech Psychobiotics Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Unique Biotech Psychobiotics Product Portfolio
6.14.5 Unique Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Psychobiotics Industry Chain Analysis
7.2 Psychobiotics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Psychobiotics Production Mode & Process Analysis
7.4 Psychobiotics Sales and Marketing
7.4.1 Psychobiotics Sales Channels
7.4.2 Psychobiotics Distributors
7.5 Psychobiotics Customer Analysis
8 Psychobiotics Market Dynamics
8.1 Psychobiotics Industry Trends
8.2 Psychobiotics Market Drivers
8.3 Psychobiotics Market Challenges
8.4 Psychobiotics Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Psychobiotics Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Psychobiotics Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Psychobiotics Market Competitive Situation by Manufacturers in 2025
Table 4. Global Psychobiotics Sales (Ton) of Key Manufacturers (2021–2026)
Table 5. Global Psychobiotics Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Psychobiotics Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Psychobiotics Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Psychobiotics Average Price (US$/Kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Psychobiotics, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Psychobiotics, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Psychobiotics, Product Types and Applications
Table 12. Global Key Manufacturers of Psychobiotics, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Psychobiotics Companies by Tier (Tier 1, Tier 2, Tier 3), based on Psychobiotics Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Psychobiotics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Psychobiotics Sales by Region (Ton), 2021–2026
Table 18. Global Psychobiotics Sales Market Share by Region (2021–2026)
Table 19. Global Psychobiotics Sales by Region (Ton), 2027–2032
Table 20. Global Psychobiotics Sales Market Share by Region (2027–2032)
Table 21. Global Psychobiotics Revenue by Region (US$ Million), 2021–2026
Table 22. Global Psychobiotics Revenue Market Share by Region (2021–2026)
Table 23. Global Psychobiotics Revenue by Region (US$ Million), 2027–2032
Table 24. Global Psychobiotics Revenue Market Share by Region (2027–2032)
Table 25. North America Psychobiotics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Psychobiotics Sales by Country (Ton), 2021–2026
Table 27. North America Psychobiotics Sales by Country (Ton), 2027–2032
Table 28. North America Psychobiotics Revenue by Country (US$ Million), 2021–2026
Table 29. North America Psychobiotics Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Psychobiotics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Psychobiotics Sales by Country (Ton), 2021–2026
Table 32. Europe Psychobiotics Sales by Country (Ton), 2027–2032
Table 33. Europe Psychobiotics Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Psychobiotics Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Psychobiotics Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Psychobiotics Sales by Region (Ton), 2021–2026
Table 37. Asia Pacific Psychobiotics Sales by Region (Ton), 2027–2032
Table 38. Asia Pacific Psychobiotics Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Psychobiotics Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Psychobiotics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Psychobiotics Sales by Country (Ton), 2021–2026
Table 42. Latin America Psychobiotics Sales by Country (Ton), 2027–2032
Table 43. Latin America Psychobiotics Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Psychobiotics Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Psychobiotics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Psychobiotics Sales by Country (Ton), 2021–2026
Table 47. Middle East and Africa Psychobiotics Sales by Country (Ton), 2027–2032
Table 48. Middle East and Africa Psychobiotics Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Psychobiotics Revenue by Country (US$ Million), 2027–2032
Table 50. Global Psychobiotics Sales (Ton) by Type (2021–2026)
Table 51. Global Psychobiotics Sales (Ton) by Type (2027–2032)
Table 52. Global Psychobiotics Sales Market Share by Type (2021–2026)
Table 53. Global Psychobiotics Sales Market Share by Type (2027–2032)
Table 54. Global Psychobiotics Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Psychobiotics Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Psychobiotics Revenue Market Share by Type (2021–2026)
Table 57. Global Psychobiotics Revenue Market Share by Type (2027–2032)
Table 58. Global Psychobiotics Price (US$/Kg) by Type (2021–2026)
Table 59. Global Psychobiotics Price (US$/Kg) by Type (2027–2032)
Table 60. Global Psychobiotics Sales (Ton) by Application (2021–2026)
Table 61. Global Psychobiotics Sales (Ton) by Application (2027–2032)
Table 62. Global Psychobiotics Sales Market Share by Application (2021–2026)
Table 63. Global Psychobiotics Sales Market Share by Application (2027–2032)
Table 64. Global Psychobiotics Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Psychobiotics Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Psychobiotics Revenue Market Share by Application (2021–2026)
Table 67. Global Psychobiotics Revenue Market Share by Application (2027–2032)
Table 68. Global Psychobiotics Price (US$/Kg) by Application (2021–2026)
Table 69. Global Psychobiotics Price (US$/Kg) by Application (2027–2032)
Table 70. Lallemand Inc Company Information
Table 71. Lallemand Inc Description and Business Overview
Table 72. Lallemand Inc Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 73. Lallemand Inc Psychobiotics Product
Table 74. Lallemand Inc Recent Developments/Updates
Table 75. Novonesis (Novozymes A/S) Company Information
Table 76. Novonesis (Novozymes A/S) Description and Business Overview
Table 77. Novonesis (Novozymes A/S) Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 78. Novonesis (Novozymes A/S) Psychobiotics Product
Table 79. Novonesis (Novozymes A/S) Recent Developments/Updates
Table 80. Bened Biomedical Company Information
Table 81. Bened Biomedical Description and Business Overview
Table 82. Bened Biomedical Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 83. Bened Biomedical Psychobiotics Product
Table 84. Bened Biomedical Recent Developments/Updates
Table 85. Sabinsa Corporation Company Information
Table 86. Sabinsa Corporation Description and Business Overview
Table 87. Sabinsa Corporation Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 88. Sabinsa Corporation Psychobiotics Product
Table 89. Sabinsa Corporation Recent Developments/Updates
Table 90. DuPont Nutrition & Biosciences Company Information
Table 91. DuPont Nutrition & Biosciences Description and Business Overview
Table 92. DuPont Nutrition & Biosciences Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 93. DuPont Nutrition & Biosciences Psychobiotics Product
Table 94. DuPont Nutrition & Biosciences Recent Developments/Updates
Table 95. Kerry Group Company Information
Table 96. Kerry Group Description and Business Overview
Table 97. Kerry Group Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 98. Kerry Group Psychobiotics Product
Table 99. Kerry Group Recent Developments/Updates
Table 100. Bioprox Company Information
Table 101. Bioprox Description and Business Overview
Table 102. Bioprox Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 103. Bioprox Psychobiotics Product
Table 104. Bioprox Recent Developments/Updates
Table 105. Chr. Hansen Company Information
Table 106. Chr. Hansen Description and Business Overview
Table 107. Chr. Hansen Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 108. Chr. Hansen Psychobiotics Product
Table 109. Chr. Hansen Recent Developments/Updates
Table 110. Mystical Biotech Company Information
Table 111. Mystical Biotech Description and Business Overview
Table 112. Mystical Biotech Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 113. Mystical Biotech Psychobiotics Product
Table 114. Mystical Biotech Recent Developments/Updates
Table 115. Synbiotech Company Information
Table 116. Synbiotech Description and Business Overview
Table 117. Synbiotech Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 118. Synbiotech Psychobiotics Product
Table 119. Synbiotech Recent Developments/Updates
Table 120. Glac biotech Co., Ltd. Company Information
Table 121. Glac biotech Co., Ltd. Description and Business Overview
Table 122. Glac biotech Co., Ltd. Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 123. Glac biotech Co., Ltd. Psychobiotics Product
Table 124. Glac biotech Co., Ltd. Recent Developments/Updates
Table 125. Ildong Bioscience Co. Ltd Company Information
Table 126. Ildong Bioscience Co. Ltd Description and Business Overview
Table 127. Ildong Bioscience Co. Ltd Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 128. Ildong Bioscience Co. Ltd Psychobiotics Product
Table 129. Ildong Bioscience Co. Ltd Recent Developments/Updates
Table 130. JuneYao Health (BioGrowing Co., Ltd) Company Information
Table 131. JuneYao Health (BioGrowing Co., Ltd) Description and Business Overview
Table 132. JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 133. JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Product
Table 134. JuneYao Health (BioGrowing Co., Ltd) Recent Developments/Updates
Table 135. Unique Biotech Company Information
Table 136. Unique Biotech Description and Business Overview
Table 137. Unique Biotech Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 138. Unique Biotech Psychobiotics Product
Table 139. Unique Biotech Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Psychobiotics Distributors List
Table 143. Psychobiotics Customers List
Table 144. Psychobiotics Market Trends
Table 145. Psychobiotics Market Drivers
Table 146. Psychobiotics Market Challenges
Table 147. Psychobiotics Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Psychobiotics
Figure 2. Global Psychobiotics Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Psychobiotics Market Share by Type: 2025 & 2032
Figure 4. Bifidobacterium Longum Product Picture
Figure 5. Lactobacillus Acidophilus Product Picture
Figure 6. Lactobacillus Casei Product Picture
Figure 7. Other Product Picture
Figure 8. Global Psychobiotics Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Psychobiotics Market Share by Application: 2025 & 2032
Figure 10. Depression
Figure 11. Stress
Figure 12. Anxiety
Figure 13. Other
Figure 14. Global Psychobiotics Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Psychobiotics Market Size (US$ Million), 2021–2032
Figure 16. Global Psychobiotics Sales (Ton), 2021–2032
Figure 17. Global Psychobiotics Average Price (US$/Kg), 2021–2032
Figure 18. Psychobiotics Report Years Considered
Figure 19. Psychobiotics Sales Share by Manufacturers in 2025
Figure 20. Global Psychobiotics Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Psychobiotics Players: Market Share by Revenue in Psychobiotics in 2025
Figure 22. Psychobiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Psychobiotics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Psychobiotics Sales Market Share by Country (2021–2032)
Figure 25. North America Psychobiotics Revenue Market Share by Country (2021–2032)
Figure 26. United States Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Psychobiotics Sales Market Share by Country (2021–2032)
Figure 29. Europe Psychobiotics Revenue Market Share by Country (2021–2032)
Figure 30. Germany Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Psychobiotics Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Psychobiotics Revenue Market Share by Region (2021–2032)
Figure 37. China Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Psychobiotics Sales Market Share by Country (2021–2032)
Figure 45. Latin America Psychobiotics Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Psychobiotics Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Psychobiotics Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Psychobiotics Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Psychobiotics by Type (2021–2032)
Figure 56. Global Revenue Market Share of Psychobiotics by Type (2021–2032)
Figure 57. Global Psychobiotics Price (US$/Kg) by Type (2021–2032)
Figure 58. Global Sales Market Share of Psychobiotics by Application (2021–2032)
Figure 59. Global Revenue Market Share of Psychobiotics by Application (2021–2032)
Figure 60. Global Psychobiotics Price (US$/Kg) by Application (2021–2032)
Figure 61. Psychobiotics Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
